RhumbLine Advisers
STJ

RhumbLine Advisers’s St Jude Medical STJ Stock Holding History

RhumbLine Advisers’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-512,817
Closed -$41.1M – 2881
2016
Q4 		$41.1M Buy
512,817
+46,173
+10% +$3.66M 0.1% 201
2016
Q3 		$37.2M Buy
466,644
+18,417
+4% +$1.49M 0.1% 209
2016
Q2 		$35M Buy
448,227
+33,381
+8% +$2.38M 0.1% 205
2016
Q1 		$22.8M Buy
414,846
+6,349
+2% +$346K 0.07% 275
2015
Q4 		$25.2M Sell
408,497
-2,305
-0.6% -$145K 0.08% 242
2015
Q3 		$25.9M Buy
410,802
+2,292
+0.6% +$164K 0.09% 225
2015
Q2 		$29.9M Buy
408,510
+4,913
+1% +$355K 0.1% 218
2015
Q1 		$26.4M Buy
403,597
+290
+0.1% +$19.3K 0.08% 239
2014
Q4 		$26.2M Sell
403,307
-3,362
-0.8% -$217K 0.08% 241
2014
Q3 		$24.5M Sell
406,669
-10,717
-3% -$700K 0.07% 240
2014
Q2 		$28.9M Sell
417,386
-31,076
-7% -$2.01M 0.08% 216
2014
Q1 		$29.3M Sell
448,462
-85
-0% -$5.53K 0.09% 212
2013
Q4 		$27.8M Sell
448,547
-25,935
-5% -$1.5M 0.08% 222
2013
Q3 		$25.5M Sell
474,482
-3,233
-0.7% -$167K 0.08% 242
2013
Q2 		$21.8M Buy
+477,715
New +$20.7M 0.07% 265

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

RhumbLine Advisers's STJ Position: Q1 2017 in Review

RhumbLine Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 512,817 shares — an estimated $41.1M sold.

RhumbLine Advisers first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $41.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • RhumbLine Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • RhumbLine Advisers sold 512,817 St Jude Medical shares in Q1 2017, an estimated $41.1M.
  • RhumbLine Advisers first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • RhumbLine Advisers's St Jude Medical position peaked at $41.1M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.